References
- SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
- RahibLSmithBDAizenbergRRosenzweigABFleshmanJMMatrisianLMProjecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United StatesCancer Res201474112913292124840647
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- ChenAYJemalAWardEMIncreasing incidence of differentiated thyroid cancer in the United States, 1988–2005Cancer2009115163801380719598221
- DaviesLWelchHGCurrent thyroid cancer trends in the United StatesJAMA Otolaryngol Head Neck Surg2014140431732224557566
- PellegritiGFrascaFRegalbutoCSquatritoSVigneriRWorldwide increasing incidence of thyroid cancer: update on epidemiology and risk factorsJ Cancer Epidemiol2013201396521223737785
- XingMMolecular pathogenesis and mechanisms of thyroid cancerNat Rev Cancer201313318419923429735
- LeboulleuxSRubinoCBaudinEPrognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosisJ Clin Endocrinol Metab200590105723572916030160
- BurnsWRZeigerMADifferentiated thyroid cancerSemin Oncol201037655756621167375
- KimSKKwonAYBackKPredictive factors of lymph node metastasis in follicular variant of papillary thyroid carcinomaAnn Surg Oncol20172492617262328685355
- LundgrenCIHallPDickmanPWZedeniusJClinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control studyCancer2006106352453116369995
- ZidanJKarenDSteinMRosenblattEBasherWKutenAPure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survivalCancer20039751181118512599223
- MustafaMKuwertTWeberKRegional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT studyEur J Nucl Med Mol Imaging20103781462146620358197
- SchneiderDFChenHNew developments in the diagnosis and treatment of thyroid cancerCA Cancer J Clin201363637439423797834
- LeeYCNaSYParkGCHanJHKimSWEunYGOccult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: a multi-institutional studySurgery2017161246547127574773
- LeeYMSungTYKimWBChungKWYoonJHHongSJRisk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissectionBr J Surg201610381020102527121346
- LiuFHKuoSFHsuehCChaoTCLinJDPostoperative recurrence of papillary thyroid carcinoma with lymph node metastasisJ Surg Oncol2015112214915426175314
- NikiforovYENikiforovaMNMolecular genetics and diagnosis of thyroid cancerNat Rev Endocrinol201171056958021878896
- XingMBRAF mutation in thyroid cancerEndocr Relat Cancer200512224526215947100
- LiuXQuSLiuRTERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancerJ Clin Endocrinol Metab2014996E1130E113624617711
- XingMLiuRLiuXBRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrenceJ Clin Oncol201432252718272625024077
- Garcia-RostanGCostaAMPereira-CastroIMutation of the PIK3CA gene in anaplastic thyroid cancerCancer Res20056522101991020716288007
- HouPLiuDShanYGenetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancerClin Cancer Res20071341161117017317825
- JiangCItoMPieningVBruckKRoederRGXiaoHTIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcriptionJ Biol Chem200427926277812778915073177
- SauveFMcBroomLDGallantJMoraitisANLabrieFGiguereVCIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinantMol Cell Biol200121134335311113208
- ZhangZTengCTEstrogen receptor alpha and estrogen receptor-related receptor alpha1 compete for binding and coactivatorMol Cell Endocrinol20011721–222323311165056
- YeXHHuangDPLuoRCNCOA5 is correlated with progression and prognosis in luminal breast cancerBiochem Biophys Res Commun2017482225325627847318
- ChenGQTianHYueWMNCOA5 low expression correlates with survival in esophageal squamous cell carcinomaMed Oncol2014311237625416054
- GaoSLiALiuFNCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinomaCancer Cell201324672573724332041
- LiuXLiuFGaoSA single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulationCancer Lett201739115216128137631
- RustemogluAErkol InalEInanirAClinical significance of NCOA5 gene rs2903908 polymorphism in Behcet’s diseaseEXCLI J20171660961728694762
- GillespieMAGoldESRamseySAPodolskyIAderemARanishJAAn LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol effluxEMBO J20153491244125825755249
- DharDSekiEKarinMNCOA5, IL-6, type 2 diabetes, and HCC: the deadly quartetCell Metab20141916724411937